First-Catch Urine Testing is Preferred Over Urethral Swabs for STD Screening in Men
For screening men for chlamydia and gonorrhea, use first-catch urine with nucleic acid amplification tests (NAATs) rather than urethral swabs—urine testing is equally or more sensitive, non-invasive, and better tolerated by patients. 1
Why Urine Testing is Superior
The USPSTF guidelines explicitly state that urine testing with NAATs is at least as sensitive as testing with urethral specimens for detecting both Chlamydia trachomatis and Neisseria gonorrhoeae in men 1. This recommendation is based on FDA-cleared NAATs that demonstrate high sensitivity and specificity across specimen types.
Key Performance Data
Recent high-quality research strongly supports urine superiority:
A 2026 prospective study of 148 men with multiple sexual partners found first-void urine detected significantly more infections than urethral swabs: First-void urine identified at least one pathogen in 128 participants versus only 100 for urethral swabs, with all 28 discordant results being urine-positive/swab-negative (p<0.001) 2
Pathogen-specific detection rates favored urine:
- N. gonorrhoeae: 55 vs 45 cases (p=0.002)
- M. genitalium: 75 vs 62 cases (p=0.0002)
- C. trachomatis: 43 vs 38 cases (p=0.063) 2
A systematic review found pooled sensitivities for chlamydia in men ranged from 84.0% to 93.1% across different NAAT platforms, with specificities exceeding 97% 3
Practical Advantages
Patient Acceptability
- Non-invasive collection eliminates the discomfort and potential trauma of urethral swabbing
- Self-collection capability reduces need for clinician involvement and increases screening uptake
- No difference in detection between symptomatic and asymptomatic men 4
Clinical Implementation
- Collect the first 20-30 mL of voided urine (first-catch urine)
- The same specimen can test for both chlamydia and gonorrhea simultaneously 1
- FDA-cleared for male urine specimens across all major NAAT platforms 1
Important Caveats
When Urethral Swabs May Still Be Needed
- Symptomatic urethritis with visible discharge: While urine performs well, direct sampling may be preferred for culture and antimicrobial susceptibility testing if treatment failure is suspected
- Point-of-care testing requirements: Some rapid tests may have different specimen requirements 5
Storage Considerations
Recent evidence shows neat urine can be stored at +4°C for up to 7 days without significant degradation of nucleic acids, eliminating the need for immediate transport medium in many cases 6
The Bottom Line
There is no clinical justification for continuing routine urethral swab collection for chlamydia and gonorrhea screening in men when NAATs are available. First-catch urine provides equal or superior detection rates, is non-invasive, and is the specimen type explicitly recommended by USPSTF guidelines 1. The most recent high-quality evidence from 2026 definitively demonstrates urine's superiority in detecting more infections 2.
The only scenario where urethral swabs might be considered is when culture-based testing is specifically needed for antimicrobial resistance profiling, but this is not a routine screening indication.